2m 2m 2m 2m 2m 2m 2m
CONTINEUM THE-A (CTNM)
NASDAQ
$17.20+$0.010 (+0.06%)
Price as of Aug 21, 2026 7:30 PM EDT- $566.6MMarket Cap
- 72.94%1-Year Change
- BiotechnologyIndustry
CONTINEUM THE-A (CTNM)
$17.20+$0.010 (+0.06%)
CTNM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.19 | ||
Change | +$1.17 (+7.30%) | ||
Open | $16.18 | ||
High | $17.35 | ||
Low | $15.88 | ||
Previous Close | $16.02 | ||
Volume | 353,907 | ||
30-Day Average Volume | 476,860 | ||
1-Week Change | 21.14% | ||
1-Month Change | 23.67% | ||
1-Year Change | 72.94% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 33.0M | ||
Total Assets | $250.4M | ||
Market Cap | $566.6M | ||
Enterprise Value | $551.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$15.2M | ||
Free Cash Flow | -$11.5M | ||
EBIT | -$15.2M | ||
EBITDA | -$15.0M | ||
Net Working Capital | $236.1M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -43 | ||
PEG | 17 | ||
Price/Free Cash Flow | -49 | ||
Price/Operating Cash Flow | -49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue